Clinical Trials Directory

Trials / Completed

CompletedNCT02051036

Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study

A Pilot Study on Effectiveness and Safety of Moxibustion for Benign Prostate Hyperplasia With Lower Urinary Tract Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
JUNGNAM KWON · Academic / Other
Sex
Male
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to explore the feasibility of moxibustion as a supplementary intervention and to assess the sample size for verifying the effectiveness and safety of integrative treatment involving moxibustion compared with conventional treatment for patients with benign prostate hyperplasia (BPH) accompanying moderate to severe lower urinary tract symptoms (LUTS).

Detailed description

Patients who diagnosed as BPH with moderate to severe LUTS aged 20 to 80 years old will be divided into two groups, one is moxibustion plus conventional therapy group and the other is conventional therapy group. Patients who belong to moxibustion plus conventional therapy group will be treated moxibustion for eight times by a Korean Medicine doctor with conventional therapy by a urologist. Patients who belong to conventional therapy group will be treated with conventional therapy only, and they can receive moxibustion therapy after the clinical trial is finished. IPSS, post void residual volume (PVR) and peak urine flow (Qmax) will be checked to evaluate the effectiveness and safety.

Conditions

Interventions

TypeNameDescription
PROCEDUREMoxibustionIn the moxibustion treatment group, 5 moxibustion points (bilateral SP6, LV3 and unilateral CV4) will be heated with indirect moxibustion (KangHwa, Korea). The moxa pillars will be removed when the patient feel hotness and require to remove them. The moxibustion will be conducted repeatedly unless patients feel the sense of heat up to seven times per session.

Timeline

Start date
2014-02-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-01-31
Last updated
2019-04-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02051036. Inclusion in this directory is not an endorsement.